Medtronic PLC MDT
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Medtronic PLC (MDT) EV/EBITDA
As of 25 September 2026, Medtronic PLC (MDT) trades at a EV/EBITDA of 13.7×. Over the past ten years it has ranged from 12.0× (June 2026) to 32.7× (April 2021); the current reading is higher than 5% of that period. That is above the Medical Devices industry median of 11.8× and above the Healthcare sector median of 10.4×.
EV/EBITDA, daily
Annual
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2026 | 13.0× | (10.80%) |
| FY2025 | 14.6× | (8.07%) |
| FY2024 | 15.9× | (5.29%) |
| FY2023 | 16.7× | (6.81%) |
| FY2022 | 18.0× | (32.63%) |
| FY2021 | 26.7× | 37.34% |
| FY2020 | 19.4× | 28.36% |
| FY2019 | 15.1× | 13.96% |
| FY2018 | 13.3× | (18.51%) |
| FY2017 | 16.3× | 2.62% |
Quarterly
| Period | EV/EBITDA | Change |
|---|---|---|
| Jul 2026 | 13.2× | 1.72% |
| Apr 2026 | 13.0× | (21.76%) |
| Jan 2026 | 16.6× | 11.91% |
| Oct 2025 | 14.9× | (1.10%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| PHG Koninklijke Philips N.V. compare | 8.6× |
| GEHC GE HealthCare Technologies Inc. compare | 11.9× |
| STE STERIS plc compare | 13.4× |
| MDT Medtronic PLC | 13.7× |
| BSX Boston Scientific Corporation compare | 13.8× |
| SYK Stryker Corporation compare | 17.2× |
| ABT Abbott Laboratories compare | 18.8× |
| DXCM DexCom, Inc. compare | 23.2× |
| EW Edwards Lifesciences Corporation compare | 28.6× |
| Medical Devices industry median | 11.8× |
| Healthcare sector median | 10.4× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement